ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 1 filers reported holding ANTARES PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $671,000 | +14.1% | 163,623 | -0.7% | 0.00% | – |
| Q4 2021 | $588,000 | -4.4% | 164,782 | -2.5% | 0.00% | -100.0% |
| Q3 2021 | $615,000 | -21.1% | 169,001 | -5.4% | 0.00% | 0.0% |
| Q2 2021 | $779,000 | -5.0% | 178,566 | -10.5% | 0.00% | 0.0% |
| Q1 2021 | $820,000 | +17.1% | 199,413 | +13.7% | 0.00% | 0.0% |
| Q4 2020 | $700,000 | +46.8% | 175,340 | -0.7% | 0.00% | 0.0% |
| Q3 2020 | $477,000 | -16.2% | 176,594 | -14.7% | 0.00% | 0.0% |
| Q2 2020 | $569,000 | +34.8% | 207,018 | +15.8% | 0.00% | 0.0% |
| Q1 2020 | $422,000 | -22.6% | 178,770 | +54.2% | 0.00% | 0.0% |
| Q4 2019 | $545,000 | +289.3% | 115,909 | +177.9% | 0.00% | – |
| Q3 2019 | $140,000 | +2.9% | 41,705 | +0.7% | 0.00% | – |
| Q2 2019 | $136,000 | +15.3% | 41,416 | +6.8% | 0.00% | – |
| Q1 2019 | $118,000 | +15.7% | 38,793 | +3.6% | 0.00% | – |
| Q4 2018 | $102,000 | +343.5% | 37,449 | +230.7% | 0.00% | – |
| Q4 2017 | $23,000 | -37.8% | 11,323 | 0.0% | 0.00% | – |
| Q3 2017 | $37,000 | +15.6% | 11,323 | +12.2% | 0.00% | – |
| Q2 2017 | $32,000 | – | 10,092 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|